Clinical Trial Update: Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update from UC Davis investigates whether oral nicotinamide riboside supplementation increases milk volume in mothers of extremely preterm i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inadequate Milk Production
• Preterm Birth

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of California, Davis | Conditions: Preterm Birth, Inadequate Milk Production | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING